AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer.
暂无分享，去创建一个
R. Greil | F. André | V. Semiglazov | G. Romieu | A. Wardley | X. Pivot | L. Gianni | S. Serrano | A. Chan | Stephen Y. T. Chan | C. Pallaud | O. Lipatov | P. Mariani | M. Mansutti | M. Lichinitser | N. Moore | S. Prot | S. Chan | A. Chan